Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis
- PMID: 1899326
- DOI: 10.1164/ajrccm/143.2.268
Comparison of bacteriostatic and bactericidal activity of isoniazid and ethionamide against Mycobacterium avium and Mycobacterium tuberculosis
Abstract
Minimal inhibitory and bactericidal concentrations (MIC and MBC) of isoniazid and ethionamide were determined in 7H12 broth in experiments with 68 Mycobacterium avium strains and 14 wild drug-susceptible M. tuberculosis strains. MICs of isoniazid for M. tuberculosis were from 0.025 to 0.05 microgram/ml, and for M. avium from 0.6 to greater than 10.0 micrograms/ml. MICs of ethionamide for M. tuberculosis were from 0.3 to 1.25 micrograms/ml, and 42.7% of M. avium strains were within the same range. Isoniazid and ethionamide were highly bactericidal against M. tuberculosis, but they had very low bactericidal activity against M. avium.
Similar articles
-
Bactericidal activity in vitro of various rifamycins against Mycobacterium avium and Mycobacterium tuberculosis.Am Rev Respir Dis. 1990 Mar;141(3):626-30. doi: 10.1164/ajrccm/141.3.626. Am Rev Respir Dis. 1990. PMID: 2155555
-
[In-vitro susceptibility of Mycobacterium avium complex to isoniazid and ethionamide].Kekkaku. 1990 Mar;65(3):243-7. Kekkaku. 1990. PMID: 2352411 Japanese.
-
Thiacetazone: in vitro activity against Mycobacterium avium and M. tuberculosis.Tubercle. 1990 Dec;71(4):287-91. doi: 10.1016/0041-3879(90)90043-8. Tubercle. 1990. PMID: 1702564
-
Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis.Expert Rev Anti Infect Ther. 2012 Sep;10(9):971-81. doi: 10.1586/eri.12.87. Expert Rev Anti Infect Ther. 2012. PMID: 23106273 Free PMC article. Review.
-
Minimum Bactericidal Concentration Techniques in Mycobacterium tuberculosis: A Systematic Review.Microb Drug Resist. 2020 Jul;26(7):752-765. doi: 10.1089/mdr.2019.0191. Epub 2020 Jan 24. Microb Drug Resist. 2020. PMID: 31977277
Cited by
-
Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.J Clin Microbiol. 1999 Oct;37(10):3179-86. doi: 10.1128/JCM.37.10.3179-3186.1999. J Clin Microbiol. 1999. PMID: 10488174 Free PMC article.
-
Assessing whether isoniazid is essential during the first 14 days of tuberculosis therapy: a phase 2a, open-label, randomised controlled trial.Lancet Microbe. 2020 Jun;1(2):e84-e92. doi: 10.1016/s2666-5247(20)30011-2. Epub 2020 Jun 8. Lancet Microbe. 2020. PMID: 33834177 Free PMC article. Clinical Trial.
-
Population Pharmacokinetics and Bayesian Dose Adjustment to Advance TDM of Anti-TB Drugs.Clin Pharmacokinet. 2021 Jun;60(6):685-710. doi: 10.1007/s40262-021-00997-0. Epub 2021 Mar 6. Clin Pharmacokinet. 2021. PMID: 33674941 Free PMC article. Review.
-
In vitro and ex vivo activities of antimicrobial agents used in combination with clarithromycin, with or without amikacin, against Mycobacterium avium.Antimicrob Agents Chemother. 1995 Mar;39(3):680-5. doi: 10.1128/AAC.39.3.680. Antimicrob Agents Chemother. 1995. PMID: 7793873 Free PMC article.
-
Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations.Antimicrob Agents Chemother. 2011 Dec;55(12):5560-7. doi: 10.1128/AAC.05429-11. Epub 2011 Oct 3. Antimicrob Agents Chemother. 2011. PMID: 21968358 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources